UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity

Clinical cancer research, 2011-02, Vol.17 (4), p.771-782

2011

Link zum Volltext

Verfügbarkeit prüfen

Maternal CD4⁺ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission

Proceedings of the National Academy of Sciences - PNAS, 2015-11, Vol.112 (44), p.13645-13650

2015

Link zum Volltext

Verfügbarkeit prüfen

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial

Annals of internal medicine, 2020-03, Vol.172 (5), p.306

2020

Link zum Volltext

Verfügbarkeit prüfen

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

Blood, 2017-01, Vol.129 (1), p.114-125

2017

Link zum Volltext

Verfügbarkeit prüfen

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

Clinical cancer research, 2018-03, Vol.24 (6), p.1315-1325

2018

Link zum Volltext

Verfügbarkeit prüfen

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system

Cancer research (Chicago, Ill.), 2014-11, Vol.74 (21), p.6260-6270

2014

Link zum Volltext

Verfügbarkeit prüfen

TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24), p.7211-7221

2013

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus-vectored vaccines for HIV and other pathogens

AIDS (London), 2020-03, Vol.34 (3), p.335-349

2020

Link zum Volltext

Verfügbarkeit prüfen

Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24), p.6447-6456

2012

Link zum Volltext

Verfügbarkeit prüfen

CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

Clinical cancer research, 2015-07, Vol.21 (13), p.2993-3002

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

Blood, 2009-06, Vol.113 (25), p.6465-6476

2009

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting Salmonella-Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors

Cancer research (Chicago, Ill.), 2011-06, Vol.71 (12), p.4183-4191

2011

Link zum Volltext

Verfügbarkeit prüfen

p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses

Clinical cancer research, 2014-09, Vol.20 (17), p.4459-4470

2014

Link zum Volltext

Verfügbarkeit prüfen

Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (15), p.5407-5414

2004

Link zum Volltext

Verfügbarkeit prüfen

Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice

Clinical cancer research, 2012-10, Vol.18 (20), p.5628-5638

2012

Link zum Volltext

Verfügbarkeit prüfen

Tumor growth control with IDO-silencing Salmonella--reply

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (14), p.4592-4593

2013

Link zum Volltext

Verfügbarkeit prüfen

Human Cytomegalovirus Proteins pp65 and Immediate Early Protein 1 Are Common Targets for CD8+ T Cell Responses in Children with Congenital or Postnatal Human Cytomegalovirus Infection

The Journal of immunology (1950), 2004-02, Vol.172 (4), p.2256-2264

2004

Link zum Volltext

Verfügbarkeit prüfen

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice

Blood, 2011-08, Vol.118 (8), p.2159-2169

2011

Link zum Volltext

Verfügbarkeit prüfen

CTLA-4 Blockade Enhances the Therapeutic Effect of an Attenuated Poxvirus Vaccine Targeting p53 in an Established Murine Tumor Model

The Journal of immunology (1950), 2003-03, Vol.170 (6), p.3401-3407

2003

Link zum Volltext

Verfügbarkeit prüfen

Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax

Biology of blood and marrow transplantation, 2019-04, Vol.25 (4), p.771-784

2019

Link zum Volltext

Verfügbarkeit prüfen

Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries

Blood, 2001-03, Vol.97 (6), p.1776-1786

2001

Link zum Volltext

Verfügbarkeit prüfen

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice

Blood, 2002-11, Vol.100 (10), p.3681-3689

2002

Link zum Volltext

Verfügbarkeit prüfen

Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2009-07, Vol.15 (7), p.872-880

2009

Link zum Volltext

Verfügbarkeit prüfen

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2015-09, Vol.21 (9), p.1653-1662

2015

Link zum Volltext

Verfügbarkeit prüfen

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells

Blood, 2004-08, Vol.104 (3), p.847-856

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Journal Of Infectious Diseases

KollektionStandalone journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(87)

Sprache

Englisch
(87)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Humans
(38)
Life Sciences & Biomedicine
(38)
Animals
(23)
Biological And Medical Sciences
(20)
Mice
(18)
Female
(15)
Hematology
(13)
Immunology
(13)
Medical Sciences
(13)
Oncology
(13)
Cytomegalovirus - Immunology
(12)
Cd8-Positive T-Lymphocytes - Immunology
(10)
Cytomegalovirus
(10)
Male
(10)
Antineoplastic Agents
(8)
Pharmacology. Drug Treatments
(8)
Phosphoproteins - Immunology
(8)
T-Lymphocytes - Immunology
(8)
Transplantation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity

Maternal CD4⁺ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system

TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy

Cytomegalovirus-vectored vaccines for HIV and other pathogens

Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth

CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting Salmonella-Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors

p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses

Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors

Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice

Tumor growth control with IDO-silencing Salmonella--reply

Human Cytomegalovirus Proteins pp65 and Immediate Early Protein 1 Are Common Targets for CD8+ T Cell Responses in Children with Congenital or Postnatal Human Cytomegalovirus Infection

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice

CTLA-4 Blockade Enhances the Therapeutic Effect of an Attenuated Poxvirus Vaccine Targeting p53 in an Established Murine Tumor Model

Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax

Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice

Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells

Aktive Filter

Suchergebnisse filtern